Clinical Trial Detail

NCT ID NCT03779113
Title An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

CLL/SLL

marginal zone B-cell lymphoma

mantle cell lymphoma

lymphoma

follicular lymphoma

Waldenstroem's macroglobulinemia

Therapies

HMPL-523

Age Groups: senior adult

No variant requirements are available.